全文获取类型
收费全文 | 7983篇 |
免费 | 661篇 |
国内免费 | 78篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 363篇 |
妇产科学 | 189篇 |
基础医学 | 995篇 |
口腔科学 | 155篇 |
临床医学 | 722篇 |
内科学 | 1885篇 |
皮肤病学 | 82篇 |
神经病学 | 914篇 |
特种医学 | 447篇 |
外科学 | 819篇 |
综合类 | 178篇 |
一般理论 | 2篇 |
预防医学 | 865篇 |
眼科学 | 129篇 |
药学 | 360篇 |
肿瘤学 | 547篇 |
出版年
2021年 | 81篇 |
2019年 | 60篇 |
2018年 | 98篇 |
2017年 | 84篇 |
2016年 | 76篇 |
2015年 | 98篇 |
2014年 | 159篇 |
2013年 | 215篇 |
2012年 | 298篇 |
2011年 | 289篇 |
2010年 | 199篇 |
2009年 | 208篇 |
2008年 | 316篇 |
2007年 | 337篇 |
2006年 | 305篇 |
2005年 | 308篇 |
2004年 | 271篇 |
2003年 | 333篇 |
2002年 | 285篇 |
2001年 | 281篇 |
2000年 | 278篇 |
1999年 | 257篇 |
1998年 | 135篇 |
1997年 | 144篇 |
1996年 | 122篇 |
1995年 | 122篇 |
1994年 | 92篇 |
1993年 | 103篇 |
1992年 | 229篇 |
1991年 | 233篇 |
1990年 | 215篇 |
1989年 | 210篇 |
1988年 | 190篇 |
1987年 | 194篇 |
1986年 | 148篇 |
1985年 | 180篇 |
1984年 | 120篇 |
1983年 | 89篇 |
1982年 | 77篇 |
1981年 | 81篇 |
1980年 | 57篇 |
1979年 | 130篇 |
1978年 | 93篇 |
1977年 | 66篇 |
1976年 | 70篇 |
1975年 | 67篇 |
1974年 | 72篇 |
1973年 | 58篇 |
1972年 | 71篇 |
1966年 | 52篇 |
排序方式: 共有8722条查询结果,搜索用时 15 毫秒
51.
52.
53.
Use of antibiotic and analgesic drugs during lactation. 总被引:2,自引:0,他引:2
Benjamin Bar-Oz Mordechai Bulkowstein Lilach Benyamini Revital Greenberg Ingrid Soriano Deena Zimmerman Oxana Bortnik Matitiahu Berkovitch 《Drug safety》2003,26(13):925-935
During lactation, multiple situations can arise that require maternal pharmacological treatment. Because of the many health advantages of human milk to infants, breast feeding should be interrupted only when the needed drug might be harmful to the nursing child and exposure via the breast milk will be sufficient to pose a risk. Since the majority of drugs have not been shown to cause adverse effects when used during lactation, and even temporary interruption of breast feeding can be difficult for the nursing dyad, decisions regarding maternal medication use during breast feeding should be based on accurate and up-to-date information. This article reviews available data on the most commonly used antibiotics and analgesics. The use of most antibiotics is considered compatible with breast feeding. Penicillins, aminopenicillins, clavulanic acid, cephalosporins, macrolides and metronidazole at dosages at the low end of the recommended dosage range are considered appropriate for use for lactating women. Fluoroquinolones should not be administered as first-line treatment, but if they are indicated, breast feeding should not be interrupted because the risk of adverse effects is low and the risks are justified. Paracetamol (acetaminophen), low-dose aspirin (acetylsalicylic acid) [up to 100 mg/day] and short-term treatment with NSAIDs, codeine, morphine and propoxyphene are considered compatible with breast feeding. Safer alternatives should be considered instead of dipyrone, aspirin at a dosage >100 mg/day and pethidine (meperidine). In the light of the many safe alternatives for pain control, breast-feeding mothers should not be allowed to experience pain or be made to feel that they must choose between analgesia and breast feeding. 相似文献
54.
55.
This article describes a study of the receptivity to and the feasibility of a patient education service for patients of private practice, primary care physicians. A stratified (by medical specialty), random sample of 400 private practice, primary care physicians in the State of Maryland was selected from the State medical society roster. In addition, a random sample of 800 health care consumers was selected from a listing of residents in a five county area of Maryland. Questionnaires were developed, pilot tested, revised, and eventually mailed to the physician and consumer samples. Completed questionnaires were obtained from 140 physicians and from 314 consumers. Results indicated that both physicians and consumers were receptive to patient education in the private practice medical setting. Based upon the findings, recommendations are offered regarding the manner in which patient education in a private practice medical setting should be organized. 相似文献
56.
P L Greenberg 《Blood reviews》1991,5(1):42-50
Therapeutic options have been rapidly evolving for management of patients with the indolent myeloid clonal hemopathies termed myelodysplastic syndromes (MDS). Heterogeneity of MDS has been demonstrated on the basis of marrow morphology and biologic features and has been useful for prognostication into high and low risk groups for transformation to acute leukemia. Such stratification has been important for evaluating responses to various treatments. These therapeutic options include the differentiation-inducing vitamins retinoic acid and vitamin D, and cytokines such as alpha and gamma interferon, to which there has been a generally low response. The use of intensive or low dose chemotherapy has been associated with relatively low response rates, few durable responses and a high degree of hemopoietic toxicity. Allogeneic bone marrow transplantation (BMT) has shown durable responses for a subset of MDS patients, particularly those who are young and who are in the low risk subgroups. however, due to the elderly nature of the majority of MDS patients, and the toxicity associated with BMT, this option has limited utility for most of these patients. Major focus has been on the recent therapeutic use of recombinant human hemopoietic growth factors, particularly G-CSF, GM-CSF and IL3. These agents have been well-tolerated and generally produce a high incidence of sustained improvements in neutrophil counts and marrow morphology, although hemoglobin and platelet counts have generally not been altered. More extensive clinical trials evaluating the impact of these hemopoietic growth factors on the natural history of MDS are ongoing. 相似文献
57.
58.
大狼毒三萜类化学成分的研究 总被引:3,自引:0,他引:3
自大戟科(Euphorbiaceae)植物大狼毒(Euphorbia nematocypha Hand—Mazz)根的乙醇提取物的苯溶解部分,经20%AgNO3硅胶层析,分离得到七个三萜类成分。根据光谱(IR,EIMS,1H—NMR和13C—NMR)和化学方法,确定其中一个化合物为新化合物,命名为大狼毒醇(nematocyphol,Ⅳa),其它化合物为已知物:印度荆芥醇乙酸酯(nepehinol acetate Ⅰ),日尔曼醇乙酸酯(germanicol acetate Ⅱ),大戟醇(euphol,Ⅲ),蒲公英醇(taraxasterol,Ⅴa),24-亚甲基环阿尔廷醇(24-methylenecycloartanol,Ⅴa)和印度荆芥醇(nepehinol,Ⅶa)。这些化合物均为首次从大狼毒中得到。 相似文献
59.
Zhao P Qin ZL Ke JS Lu Y Liu M Pan W Zhao LJ Cao J Qi ZT 《第二军医大学学报》2005,26(10):1167-1167
SARS-CoV isa newly identified coronavirus that causes severe acute respiratory syndrome (SARS). Currently, there is no effective method available for prophylaxis and treatment of SARS-CoVinfections. In the present study, the influence of small interfering RNA (siRNA) on SARS-CoV nucleocapsid (N) protein expression was detected in cultured cells and mouse muscles. Four siRNA expression cassettes driven by mouse U6 promoter targeting SARS-CoV N gene were prepared, and their inhibitory effects on expression of N and enhanced green fluorescence protein (EGFP) fusion protein were observed. 相似文献
60.
The spectrum of ciclosporin nephrotoxicity 总被引:2,自引:0,他引:2